Skip to main content

10.05.2024 | Original Article

Conditional survival nomogram for patients with colon mucinous adenocarcinoma to predict prognosis: a dynamic survival analysis

verfasst von: Huajun Cai, Ye Wang, Shoufeng Li, Zhen Pan, Tianbao Xu, Yunjin Wang, Yiyi Zhang, Jinfu Zhuang, Xing Liu, Guoxian Guan

Erschienen in: Updates in Surgery

Einloggen, um Zugang zu erhalten

Abstract

The aim was to assess conditional survival for colon mucinous adenocarcinoma (MAC) patients, and to construct nomograms to predict conditional survival probability. Survival analysis was done using conditional survival, which was defined as the probability of surviving additional y years for patients who have survived for x years. The mathematical definition was express as: CS (y|x) = S (x + y)/S (x). Cox regression analyses were used to identify prognostic factors. A nomogram is constructed to predict conditional disease-free survival (DFS) and overall survival (OS) probability according to years that already survive. A total of 179 colon MAC patients were included. The 5-year DFS was 67% after surgery, and the 5-year survival probability of patients, who already survived 1, 2, 3, and 4 years were 75%, 87%, 95%, and 98%, respectively. The 5-year OS was 73% after surgery and increased to 76%, 82%, 88%, and 92% at 1, 2, 3, and 4 years, respectively. Subgroup analyses demonstrated the superiority of conditional survival was more pronounced in advanced stages than in stage I. And pT stage, pN stage, and lymphovascular invasion were significantly associated with DFS and OS. Conditional survival nomograms were constructed to predict the 5-year conditional DFS and OS probability given survival for 1, 2, 3, 4 years after surgery. Conditional survival can provide dynamic survival probability according to years that already survive, especially for patients with advanced stages. Taking into account the years already survived accounted for, novel nomograms contributed to effectively predicting conditional survival.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249CrossRefPubMed Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249CrossRefPubMed
2.
Zurück zum Zitat Siegel RL, Miller KD, Goding Sauer A et al (2020) Colorectal cancer statistics, 2020. CA Cancer J Clin 70:145–164CrossRefPubMed Siegel RL, Miller KD, Goding Sauer A et al (2020) Colorectal cancer statistics, 2020. CA Cancer J Clin 70:145–164CrossRefPubMed
3.
Zurück zum Zitat O'Connell E, Reynolds IS, McNamara DA et al (2021) Resistance to cell death in mucinous colorectal cancer—a review. Cancers (Basel) 13:1389 O'Connell E, Reynolds IS, McNamara DA et al (2021) Resistance to cell death in mucinous colorectal cancer—a review. Cancers (Basel) 13:1389
4.
Zurück zum Zitat Luo C, Cen S, Ding G, Wu W (2019) Mucinous colorectal adenocarcinoma: clinical pathology and treatment options. Cancer Commun (Lond) 39:13PubMed Luo C, Cen S, Ding G, Wu W (2019) Mucinous colorectal adenocarcinoma: clinical pathology and treatment options. Cancer Commun (Lond) 39:13PubMed
5.
Zurück zum Zitat Li C, Zheng H, Jia H et al (2019) Prognosis of three histological subtypes of colorectal adenocarcinoma: a retrospective analysis of 8005 Chinese patients. Cancer Med 8:3411–3419CrossRefPubMedPubMedCentral Li C, Zheng H, Jia H et al (2019) Prognosis of three histological subtypes of colorectal adenocarcinoma: a retrospective analysis of 8005 Chinese patients. Cancer Med 8:3411–3419CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Hugen N, Brown G, Glynne-Jones R et al (2016) Advances in the care of patients with mucinous colorectal cancer. Nat Rev Clin Oncol 13:361–369CrossRefPubMed Hugen N, Brown G, Glynne-Jones R et al (2016) Advances in the care of patients with mucinous colorectal cancer. Nat Rev Clin Oncol 13:361–369CrossRefPubMed
7.
Zurück zum Zitat Zhang J, Xie X, Wu Z et al (2021) Mucinous adenocarcinoma predicts poor response and prognosis in patients with locally advanced rectal cancer: a pooled analysis of individual participant data from 3 prospective studies. Clin Colorectal Cancer 20:e240–e248CrossRefPubMed Zhang J, Xie X, Wu Z et al (2021) Mucinous adenocarcinoma predicts poor response and prognosis in patients with locally advanced rectal cancer: a pooled analysis of individual participant data from 3 prospective studies. Clin Colorectal Cancer 20:e240–e248CrossRefPubMed
8.
Zurück zum Zitat Catalano V, Bergamo F, Cremolini C et al (2020) Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients. J Cancer Res Clin Oncol 146:493–501CrossRefPubMed Catalano V, Bergamo F, Cremolini C et al (2020) Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients. J Cancer Res Clin Oncol 146:493–501CrossRefPubMed
9.
Zurück zum Zitat Kanda M, Oba K, Aoyama T et al (2018) Clinical signatures of mucinous and poorly differentiated subtypes of colorectal adenocarcinomas by a propensity score analysis of an independent patient database from three phase III trials. Dis Colon Rectum 61:461–471CrossRefPubMed Kanda M, Oba K, Aoyama T et al (2018) Clinical signatures of mucinous and poorly differentiated subtypes of colorectal adenocarcinomas by a propensity score analysis of an independent patient database from three phase III trials. Dis Colon Rectum 61:461–471CrossRefPubMed
10.
Zurück zum Zitat Polley MY, Lamborn KR, Chang SM et al (2011) Conditional probability of survival in patients with newly diagnosed glioblastoma. J Clin Oncol 29:4175–4180CrossRefPubMedPubMedCentral Polley MY, Lamborn KR, Chang SM et al (2011) Conditional probability of survival in patients with newly diagnosed glioblastoma. J Clin Oncol 29:4175–4180CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Wang P, Sun Z, Wang W et al (2018) Conditional survival of patients with gastric cancer who undergo curative resection: a multi-institutional analysis in China. Cancer 124:916–924CrossRefPubMed Wang P, Sun Z, Wang W et al (2018) Conditional survival of patients with gastric cancer who undergo curative resection: a multi-institutional analysis in China. Cancer 124:916–924CrossRefPubMed
12.
Zurück zum Zitat Ejaz A, Pawlik TM (2021) Conditional recurrence-free survival for patients with gallbladder cancer: a personalized resource for patients and providers. Ann Surg Oncol 28:2436–2437CrossRefPubMed Ejaz A, Pawlik TM (2021) Conditional recurrence-free survival for patients with gallbladder cancer: a personalized resource for patients and providers. Ann Surg Oncol 28:2436–2437CrossRefPubMed
13.
Zurück zum Zitat Shah MM, Meyer BI, Rhee K et al (2020) Conditional survival analysis of hepatocellular carcinoma. J Surg Oncol 122:684-690 Shah MM, Meyer BI, Rhee K et al (2020) Conditional survival analysis of hepatocellular carcinoma. J Surg Oncol 122:684-690
14.
Zurück zum Zitat Lian L, Xu XF, Shen XM et al (2021) Pattern of distant metastases and predictive nomograms in colorectal mucinous adenocarcinoma: a SEER analysis. J Gastrointest Oncol 12:2906–2918CrossRefPubMedPubMedCentral Lian L, Xu XF, Shen XM et al (2021) Pattern of distant metastases and predictive nomograms in colorectal mucinous adenocarcinoma: a SEER analysis. J Gastrointest Oncol 12:2906–2918CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Dai D, Zhou B, Zhong Y et al (2019) Survival of patients with resected primary colorectal mucinous adenocarcinoma: a competing risk nomogram analysis. Oncol Lett 18:6594–6604PubMedPubMedCentral Dai D, Zhou B, Zhong Y et al (2019) Survival of patients with resected primary colorectal mucinous adenocarcinoma: a competing risk nomogram analysis. Oncol Lett 18:6594–6604PubMedPubMedCentral
16.
Zurück zum Zitat Skuladottir H, Olsen JH (2003) Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. J Clin Oncol 21:3035–3040CrossRefPubMed Skuladottir H, Olsen JH (2003) Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. J Clin Oncol 21:3035–3040CrossRefPubMed
17.
Zurück zum Zitat Wang SJ, Emery R, Fuller CD et al (2007) Conditional survival in gastric cancer: a SEER database analysis. Gastric Cancer 10:153–158CrossRefPubMed Wang SJ, Emery R, Fuller CD et al (2007) Conditional survival in gastric cancer: a SEER database analysis. Gastric Cancer 10:153–158CrossRefPubMed
18.
Zurück zum Zitat Dikken JL, Baser RE, Gonen M et al (2013) Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer. Ann Surg Oncol 20:1623–1630CrossRefPubMed Dikken JL, Baser RE, Gonen M et al (2013) Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer. Ann Surg Oncol 20:1623–1630CrossRefPubMed
19.
Zurück zum Zitat Zhou YW, Long YX, Chen Y et al (2021) First-line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component. Cancer Med 10:3388–3402CrossRefPubMedPubMedCentral Zhou YW, Long YX, Chen Y et al (2021) First-line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component. Cancer Med 10:3388–3402CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Catalano V, Loupakis F, Graziano F et al (2012) Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer. Ann Oncol 23:135–141CrossRefPubMed Catalano V, Loupakis F, Graziano F et al (2012) Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer. Ann Oncol 23:135–141CrossRefPubMed
21.
Zurück zum Zitat Inamura K, Yamauchi M, Nishihara R et al (2015) Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma. Ann Surg Oncol 22:1226–1235CrossRefPubMed Inamura K, Yamauchi M, Nishihara R et al (2015) Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma. Ann Surg Oncol 22:1226–1235CrossRefPubMed
22.
Zurück zum Zitat Hyngstrom JR, Hu CY, Xing Y et al (2012) Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol 19:2814–2821CrossRefPubMedPubMedCentral Hyngstrom JR, Hu CY, Xing Y et al (2012) Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol 19:2814–2821CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Mekenkamp LJ, Heesterbeek KJ, Koopman M et al (2012) Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer. Eur J Cancer 48:501–509CrossRefPubMed Mekenkamp LJ, Heesterbeek KJ, Koopman M et al (2012) Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer. Eur J Cancer 48:501–509CrossRefPubMed
24.
Zurück zum Zitat Soliman BG, Karagkounis G, Church JM et al (2018) Mucinous histology signifies poor oncologic outcome in young patients with colorectal cancer. Dis Colon Rectum 61:547–553CrossRefPubMed Soliman BG, Karagkounis G, Church JM et al (2018) Mucinous histology signifies poor oncologic outcome in young patients with colorectal cancer. Dis Colon Rectum 61:547–553CrossRefPubMed
25.
Zurück zum Zitat Kim CW, Cha JM, Kwak MS (2021) Identification of potential biomarkers and biological pathways for poor clinical outcome in mucinous colorectal adenocarcinoma. Cancers (Basel) 13:3280 Kim CW, Cha JM, Kwak MS (2021) Identification of potential biomarkers and biological pathways for poor clinical outcome in mucinous colorectal adenocarcinoma. Cancers (Basel) 13:3280
26.
Zurück zum Zitat Dong B, Chen Y, Lyu G (2022) Prognostic nomograms for predicting overall survival and cancer-specific survival of patients with very early onset colorectal cancer: a population‑based analysis. Bosn J Basic Med Sci 22:803-817 Dong B, Chen Y, Lyu G (2022) Prognostic nomograms for predicting overall survival and cancer-specific survival of patients with very early onset colorectal cancer: a population‑based analysis. Bosn J Basic Med Sci 22:803-817
27.
Zurück zum Zitat Barresi V, Reggiani Bonetti L, Vitarelli E et al (2012) Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: prognostic relevance and correlation with nodal micrometastases. Am J Surg Pathol 36:66–72CrossRefPubMed Barresi V, Reggiani Bonetti L, Vitarelli E et al (2012) Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: prognostic relevance and correlation with nodal micrometastases. Am J Surg Pathol 36:66–72CrossRefPubMed
28.
Zurück zum Zitat Hamy AS, Lam GT, Laas E et al (2018) Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma. Breast Cancer Res Treat 169:295–304CrossRefPubMed Hamy AS, Lam GT, Laas E et al (2018) Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma. Breast Cancer Res Treat 169:295–304CrossRefPubMed
29.
Zurück zum Zitat Wu L, Liang Y, Zhang C et al (2019) Prognostic significance of lymphovascular infiltration in overall survival of gastric cancer patients after surgery with curative intent. Chin J Cancer Res 31:785–796CrossRefPubMedPubMedCentral Wu L, Liang Y, Zhang C et al (2019) Prognostic significance of lymphovascular infiltration in overall survival of gastric cancer patients after surgery with curative intent. Chin J Cancer Res 31:785–796CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Skancke M, Arnott SM, Amdur RL et al (2019) Lymphovascular invasion and perineural invasion negatively impact overall survival for stage II adenocarcinoma of the colon. Dis Colon Rectum 62:181–188CrossRefPubMed Skancke M, Arnott SM, Amdur RL et al (2019) Lymphovascular invasion and perineural invasion negatively impact overall survival for stage II adenocarcinoma of the colon. Dis Colon Rectum 62:181–188CrossRefPubMed
31.
Zurück zum Zitat Rönnow CF, Arthursson V, Toth E et al (2022) Lymphovascular infiltration, not depth of invasion, is the critical risk factor of metastases in early colorectal cancer: retrospective population-based cohort study on prospectively collected data. Including Validation Ann Surg 275:e148–e154PubMed Rönnow CF, Arthursson V, Toth E et al (2022) Lymphovascular infiltration, not depth of invasion, is the critical risk factor of metastases in early colorectal cancer: retrospective population-based cohort study on prospectively collected data. Including Validation Ann Surg 275:e148–e154PubMed
32.
Zurück zum Zitat Nikberg M, Chabok A, Letocha H et al (2016) Lymphovascular and perineural invasion in stage II rectal cancer: a report from the Swedish colorectal cancer registry. Acta Oncol 55:1418–1424CrossRefPubMed Nikberg M, Chabok A, Letocha H et al (2016) Lymphovascular and perineural invasion in stage II rectal cancer: a report from the Swedish colorectal cancer registry. Acta Oncol 55:1418–1424CrossRefPubMed
Metadaten
Titel
Conditional survival nomogram for patients with colon mucinous adenocarcinoma to predict prognosis: a dynamic survival analysis
verfasst von
Huajun Cai
Ye Wang
Shoufeng Li
Zhen Pan
Tianbao Xu
Yunjin Wang
Yiyi Zhang
Jinfu Zhuang
Xing Liu
Guoxian Guan
Publikationsdatum
10.05.2024
Verlag
Springer International Publishing
Erschienen in
Updates in Surgery
Print ISSN: 2038-131X
Elektronische ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-024-01869-5

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.